Sharekhan is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 2430 in its research report dated February 20, 2020.

Buy Divi’s Laboratories target of Rs 2200: Sharekhan

Sharekhan is bullish on Divi’s Laboratories has recommended buy rating on the stock with a target price of Rs 2200 in its research report dated February 06, 2020.

Hold Divi's Laboratories; target of Rs 1850: ICICI Direct

ICICI Direct recommended hold rating on Divi's Laboratories with a target price of Rs 1850 in its research report dated November 06, 2019.

Buy Divi’s Laboratories; target of Rs 1800: Sharekhan

Sharekhan is bullish on Divi’s Laboratories has recommended buy rating on the stock with a target price of Rs 1800 in its research report dated August 14, 2019.

Hold Divi's Laboratories; target of Rs 1640: ICICI Direct

ICICI Direct recommended hold rating on Divi's Laboratories with a target price of Rs 1640 in its research report dated August 12, 2019.

Buy Divi’s Laboratories; target of Rs 1850: Sharekhan

Sharekhan is bullish on Divi’s Laboratories has recommended buy rating on the stock with a target price of Rs 1850 in its research report dated May 28, 2019.

Buy Divi’s Laboratories; target of Rs 1800: ICICI Direct

ICICI Direct is bullish on Divi’s Laboratories has recommended buy rating on the stock with a target price of Rs 1800 in its research report dated February 04, 2019.

Buy Divis Laboratories; target of Rs 1670: Sharekhan

Sharekhan bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 1670 in its research report dated September 17, 2018.

Buy Divis Laboratories; target of Rs 1275: Sharekhan

Sharekhan is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 1275 in its research report dated November 02, 2017.

Hold Divi’s Laboratories; target of Rs 1090: ICICI Direct

ICICI Direct recommended hold rating on Divi’s Laboratories with a target price of Rs 1090 in its research report dated November 03, 2017.

Buy Divi's Laboratories; target of Rs 1080: Axis Direct

Axis Direct is bullish on Divi's Laboratories has recommended buy rating on the stock with a target price of Rs 1080 in its research report dated October 03, 2017.

Hold Divi’s Laboratories; target of Rs 1040: Sharekhan

Sharekhan is recommended hold rating on Divi’s Laboratories with a target price of Rs 1040 in its research report dated September 20, 2017.

Hold Divi’s Laboratories; target of Rs 665: ICICI Direct

ICICI Direct recommended hold rating on Divi’s Laboratories with a target price of Rs 665 in its research report dated July 24, 2017.

Hold Divi’s Laboratories; target of Rs 740: ICICI Direct

ICICI Direct has recommended Hold rating on Divi’s Laboratories with a target price of Rs 740 in its research report dated July 10, 2017.

Hold Divi's Laboratories; target of Rs 600: Axis Direct

Axis Direct recommended hold rating on Divi's Laboratories with a target price of Rs 600 in its research report dated June 06, 2017.

Hold Divi's Laboratories; target of Rs 585: Edelweiss

Edelweiss recommended hold rating on Divi's Laboratories with a target price of Rs 585 in its research report dated May 26, 2017.

Hold Divi’s Laboratories; target of Rs 625: ICICI Direct

ICICI Direct recommended hold rating on Divi’s Laboratories with a target price of Rs 625 in its research report dated May 29, 2017.

Hold Divi's Laboratories; target of Rs 690: Axis Direct

Axis Direct recommended hold rating on Divi's Laboratories with a target price of Rs 690 in its research report dated April 10, 2017.

Top trading ideas by SP Tulsian

In an interview to CNBC-TV18 SP Tulsian, sptulsian.com shared his reading and outlook on the market and also gave recommendations on various stocks.

Hold Divi's Laboratories; target of Rs 740: Axis Direct

Axis Direct recommended hold rating on Divi's Laboratories with a target price of Rs 740 in its research report dated February 10, 2017.

Buy Divi‘s Laboratories; target of Rs 925: ICICI Direct

ICICI Direct is bullish on Divi‘s Laboratories has recommended buy rating on the stock with a target price of Rs 925 in its research report dated February 07, 2017.

Buy Divi‘s Laboratories; target of Rs 925: ICICI Direct

ICICI Direct is bullish on Divi‘s Laboratories has recommended buy rating on the stock with a target price of Rs 925 in its research report dated February 07, 2017.

Buy Divis Laboratories; target of Rs 1400: Religare

Religare is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 1400 in its research report dated December 07, 2016.

Buy Divi‘s Laboratories; target of Rs 1305: ICICI Direct

ICICI Direct is bullish on Divi‘s Laboratories has recommended buy rating on the stock with a target price of Rs 1305 in its research report dated November 17, 2016.

Buy Divis Laboratories; target of Rs 1260: Religare

Religare is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 1260 in its research report dated August 16, 2016.